期刊文献+

Urinary metabonomics of stomach cancer assessed by rapid resolution liquid chromatography/time-of-flight mass spectrometry 被引量:5

Urinary metabonomics of stomach cancer assessed by rapid resolution liquid chromatography/time-of-flight mass spectrometry
原文传递
导出
摘要 Background Stomach cancer is among the most commonly occurring malignancies worldwide. It would be beneficial to develop a urine-based assay whereby patients with undiagnosed stomach cancer could be screened and their cancer detected in the eadiest stages. Methods A urinary metabonomics method based on ultra-performance liquid chromatography combined with quadruple time-of-flight mass spectrometry was used to analyze urine samples from patients with stomach cancer and healthy controls. Results Statistical analysis revealed a clear separation of patients and healthy controls using the aforementioned methodology. Some significantly changed metabolites were identified. Conclusions Use of the metabonomics method in patients with stomach cancer could effectively detect distinct changes in urinary metabolites and had the capacity to detect cancer; therefore, it may be a valuable tool in earlier diagnosis. Furthermore, the detection and identification of altered metabolites in the current study may help elucidate possible mechanisms involved in stomach cancer. Background Stomach cancer is among the most commonly occurring malignancies worldwide. It would be beneficial to develop a urine-based assay whereby patients with undiagnosed stomach cancer could be screened and their cancer detected in the eadiest stages. Methods A urinary metabonomics method based on ultra-performance liquid chromatography combined with quadruple time-of-flight mass spectrometry was used to analyze urine samples from patients with stomach cancer and healthy controls. Results Statistical analysis revealed a clear separation of patients and healthy controls using the aforementioned methodology. Some significantly changed metabolites were identified. Conclusions Use of the metabonomics method in patients with stomach cancer could effectively detect distinct changes in urinary metabolites and had the capacity to detect cancer; therefore, it may be a valuable tool in earlier diagnosis. Furthermore, the detection and identification of altered metabolites in the current study may help elucidate possible mechanisms involved in stomach cancer.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第10期1930-1933,共4页 中华医学杂志(英文版)
关键词 stomach cancer metabonomics rapid resolution liquid chromatography-quadruple time of flight massspectrometry biomarker stomach cancer, metabonomics rapid resolution liquid chromatography-quadruple time of flight massspectrometry, biomarker
  • 相关文献

参考文献27

  • 1Neugut AI, Hayek M, Howe G. Epidemiology of gastric cancer. Semin Oncol 1996; 23: 281-291.
  • 2Werner M, Becker KF, Keller G, Htfler H. Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Onco12001; 127: 207-216.
  • 3Brenner H, Rothenbacher D, Amdt V. Epidemiology of stomach cancer. Methods Mol Bio12009; 472: 467-477.
  • 4Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Onco12005; 16: 481-488.
  • 5Workman P, de Bono J. Targeted therapeutics for cancer treatment: major progress towards personalised molecular medicine. Curr Opin Pharmaco12008; 8: 359-362.
  • 6Stratton MR, Campbell P J, Futreal PA. The cancer genome. Nature 2009; 458: 719-724.
  • 7Schlabach MR, Luo J, Solimini NL, Hu G, Xu Q, Li MZ, et al. Cancer proliferation gene discovery through functional genomics. Science 2008; 319: 620-624.
  • 8Ma Y, Peng J, Liu W, Zhang P, Huang L, Gao B, et al. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer. Mol Cell Proteomics 2009; 8: 1878-1890.
  • 9Hanash SM, Pitteri S J, Faca VM. Mining the plasma proteome for cancer biomarkers. Nature 2008; 452: 571-579.
  • 10Cheever MA, Allison JP, Ferris AS, Finn O J, Hastings BM, Hecht TT, et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 2009; 15: 5323-5337.

同被引文献83

  • 1Ping Liu,Xiao-Yong Zhang,Yun Shao,Dao-Fu Zhang.Microsatellite instability in gastric cancer and pre-cancerous lesions[J].World Journal of Gastroenterology,2005,11(31):4904-4907. 被引量:7
  • 2Hopkins AL. Network pharmacology[J]. Nature Biotechnology, 2007,25(10):1110-1111.
  • 3Hopkins AL. Network pharmacology: the next paradigm in drug discovery[J]. Nature Chemical Biology, 2008,4(11):682-690.
  • 4Tanaka T, Oka T, Shimada Y, et al. Pharmacogenomics of cardiovascular pharmacology:Pharmacogenomic network of cardiovascular disease models[J].Journal of Pharmacological Sciences,2008,107(1):8-14.
  • 5Cunsolo V, Muccilli V, Saletti R, et al. Mass spectrometry in food proteomics: a tutorial[J]. Journal of Mass Spectometry,2014,49(9):768-784.
  • 6Valérie B, Lise P, Evelyne M, et al. Formalin-fixed paraffin embedded tissue: the holy grail of clinical proteomics[J]. Proteomics Clinical Application, 2014,8(10):735-736.
  • 7Robert JM, Shane LR. Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases[J]. Mass Spectrometry Reviews, 2012,31(1):70-95.
  • 8Qiu YP, Zhou BS, Su MM, et al. Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients[J]. International Journal of Molecular Sciences,2013,14(4):8047-8061.
  • 9Zhu H,Zhang J,Kim MT, et al.Big data in chemical toxicity research: The use of high-throughput screening assays to identify potential toxicants[J]. Chemical Research in Toxicology, 2014,27(10):1643-1651.
  • 10Zhang GB, Li QY, Chen QL, et al. Network pharmacology: A new approach for Chinese herbal medicine research[J]. evidence-based Complementary and Alternative Medicine, 2013, 62(1):423.

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部